Portfolio concentration
As of March 31, 2026 · N-PORT
Holdings
55
Top-10 weight
53.91%
Effective holdings
?
The number of equal-weight positions that would produce this portfolio's concentration (1 ÷ Herfindahl index). A 500-stock fund dominated by a few mega-caps might have only ~100 effective holdings.
24
Crowding
?
The value-weighted average number of funds that also own this fund's positions. High = consensus/crowded picks; low = holdings few other funds own.
907.0
Holdings
As of March 31, 2026 · N-PORT| # | Security | Ticker | Shares | Value | % of fund |
|---|---|---|---|---|---|
| 1 | UNITED THERAPEUTICS CORP DEL | — | 34,623 | $20.53M | 8.77% |
| 2 | ALIGN TECHNOLOGY INC | — | 108,058 | $18.52M | 7.91% |
| 3 | LILLY ELI and CO | — | 16,883 | $15.53M | 6.63% |
| 4 | CHUGAI PHARMA CO | — | 225,065 | $12.21M | 5.21% |
| 5 | OPTION | NVO US | 330,915 | $12.16M | 5.19% |
| 6 | ABBVIE INC | — | 49,149 | $10.69M | 4.56% |
| 7 | JAZZ PHARMA PLC | — | 52,291 | $9.89M | 4.22% |
| 8 | PURECYCLE TECHNOLOGIES INC | — | 1,790,023 | $9.29M | 3.97% |
| 9 | THERMO FISHER SCIENTIFIC INC | — | 17,598 | $8.65M | 3.69% |
| 10 | GILEAD SCIENCES INC | — | 62,011 | $8.64M | 3.69% |
| 11 | REGENERON PHARMACEUTICALS INC | — | 11,017 | $8.51M | 3.63% |
| 12 | BIOHAVEN LTD | — | 908,165 | $7.68M | 3.28% |
| 13 | 10X GENOMICS INC | — | 356,842 | $7.58M | 3.23% |
| 14 | JOHNSON&JOHNSON | — | 27,111 | $6.63M | 2.83% |
| 15 | 3M CO | — | 43,851 | $6.37M | 2.72% |
| 16 | WARBY PARKER INC | — | 293,990 | $6.19M | 2.64% |
| 17 | DANAHER CORP | — | 32,655 | $6.19M | 2.64% |
| 18 | BENITEC BIOPHARMA INC | — | 568,353 | $6.05M | 2.58% |
| 19 | AMGEN INC | — | 16,015 | $5.63M | 2.41% |
| 20 | ASTRAZENECA PLC | — | 26,097 | $5.15M | 2.20% |
| 21 | INTUITIVE SURGICAL INC | — | 10,884 | $5.02M | 2.14% |
| 22 | CVS HEALTH CORP | — | 53,026 | $3.81M | 1.63% |
| 23 | VERTEX PHARMACEUTICALS INC | — | 8,020 | $3.58M | 1.53% |
| 24 | EYEPOINT PHARMACEUTICALS INC | — | 275,577 | $3.55M | 1.52% |
| 25 | ALIGNMENT HEALTHCARE INC | — | 193,071 | $3.40M | 1.45% |
| 26 | ESTABLISHMENT LABS HOLDINGS INC | ESTA | 53,585 | $3.04M | 1.30% |
| 27 | GE HEALTHCARE TECHNOLOGIES INC WI | — | 39,686 | $2.82M | 1.21% |
| 28 | APELLIS PHARMACEUTICALS INC | — | 57,335 | $2.31M | 0.98% |
| 29 | GUARDANT HEALTH INC | — | 21,046 | $1.94M | 0.83% |
| 30 | INSMED INC | — | 10,328 | $1.69M | 0.72% |
| 31 | ABBOTT LABS | — | 15,674 | $1.61M | 0.69% |
| 32 | PACIRA BIOSCIENCES INC | — | 63,334 | $1.43M | 0.61% |
| 33 | EDWARDS LIFESCIENCES CORP | — | 14,231 | $1.14M | 0.49% |
| 34 | DREYFUS TRSY OBLIG CASH M | — | 931,316 | $931.32K | 0.40% |
| 35 | FULCRUM THERAPEUTICS INC | — | 117,254 | $899.34K | 0.38% |
| 36 | COOPER COS INC | — | 10,050 | $718.58K | 0.31% |
| 37 | BOSTON SCIENTIFIC CORP | — | 11,447 | $718.30K | 0.31% |
| 38 | STRYKER CORP | — | 1,728 | $567.80K | 0.24% |
| 39 | TG THERAPEUTICS INC | — | 16,223 | $538.93K | 0.23% |
| 40 | UNITEDHEALTH GRP | — | 1,829 | $494.91K | 0.21% |
| 41 | NEUROCRINE BIOSCIENCES INC | — | 2,532 | $333.57K | 0.14% |
| 42 | ZIMMER BIOMET HO | — | 3,351 | $303.00K | 0.13% |
| 43 | FLUOR CORP | — | 4,754 | $221.77K | 0.09% |
| 44 | TELEFLEX INC | — | 1,121 | $134.08K | 0.06% |
| 45 | SAREPTA THERAPEUTICS INC | — | 5,866 | $127.64K | 0.05% |
| 46 | Icon Public Limited Company | ICLR | 1,151 | $127.37K | 0.05% |
| 47 | PRAXIS PRECISION MEDICINES INC | — | 285 | $91.82K | 0.04% |
| 48 | VERALTO CORP | — | 594 | $52.52K | 0.02% |
| 49 | BRISTOL-MYERS SQUIBB CO | — | 839 | $50.89K | 0.02% |
| 50 | AGILON HEALTH IN | — | 6,429 | $50.85K | 0.02% |
1 / 2
Next ›
Machine-readable: JSON · Markdown. Programmatic access via the agent surface.